Controversy and debate on dengue vaccine series-paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.

MLA

Dans, Antonio L., et al. “Controversy and Debate on Dengue Vaccine Series-Paper 3: Final Response to Review of a Licensed Dengue Vaccine: Inappropriate Subgroup Analyses and Selective Reporting May Cause Harm in Mass Vaccination Programs.” Journal of Clinical Epidemiology, vol. 95, Mar. 2018, p. 142. EBSCOhost, https://doi.org/10.1016/j.jclinepi.2017.12.025.

APA

Dans, A. L., Dans, L. F., Lansang, M. A. D., Silvestre, M. A. A., & Guyatt, G. H. (2018). Controversy and debate on dengue vaccine series-paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. Journal of Clinical Epidemiology, 95, 142. https://doi.org/10.1016/j.jclinepi.2017.12.025

Chicago

Dans, Antonio L, Leonila F Dans, Mary Ann D Lansang, Maria Asuncion A Silvestre, and Gordon H Guyatt. 2018. “Controversy and Debate on Dengue Vaccine Series-Paper 3: Final Response to Review of a Licensed Dengue Vaccine: Inappropriate Subgroup Analyses and Selective Reporting May Cause Harm in Mass Vaccination Programs.” Journal of Clinical Epidemiology 95 (March): 142. doi:10.1016/j.jclinepi.2017.12.025.